Weekly Intelligence · 8 articles

Vet Industry Intel: Jun 21 – Jun 27, 2026

High-signal veterinary industry stories triangulated from multiple sources, scored for relevance, and grouped by event type.

Regulatory & Policy (5) Products & Technology (3)

Regulatory & Policy

Jun 24, 2026 [8/10] Vaccine Advisor

CDC, FDA Tackle New World Screwworm, Including Drug Authorization

The CDC and FDA are addressing the New World Screwworm, which includes issuing new drug authorizations.

CDC · FDA · Vaccine Advisor

Jun 23, 2026 [7/10] Stock Titan

Jaguar Health seeks full FDA approval for dog diarrhea drug

Jaguar Health is seeking full FDA approval for its dog diarrhea medication.

Jaguar Health · FDA

Jun 26, 2026 [7/10] American Veterinary Medical Association

Latest FDA approvals include BRD treatment for cattle, several drugs for dogs

The FDA recently approved new treatments for bovine respiratory disease (BRD) in cattle and several new drugs for dogs, as reported by the American Veterinary Medical Association.

FDA · American Veterinary Medical Association

Jun 27, 2026 [7/10] American Veterinary Medical Association

Bedinvetmab (Librela/Beransa) in dogs raises safety concerns, including rapidly progressive osteoarthritis, and warrants vigilant adverse event reporting

The AVMA reported safety concerns regarding the canine drug bedinvetmab (Librela/Beransa), highlighting risks such as rapidly progressive osteoarthritis and urging vigilant adverse event reporting.

American Veterinary Medical Association

Jun 27, 2026 [7/10] AVMA Journals

Bedinvetmab (Librela/Beransa) in dogs raises safety concerns, including rapidly progressive osteoarthritis, and warrants vigilant adverse event reporting

A report in AVMA Journals highlights safety concerns regarding the canine monoclonal antibody bedinvetmab (Librela/Beransa), noting potential risks such as rapidly progressive osteoarthritis and emphasizing the need for vigilant adverse event reporting.

AVMA Journals

Products & Technology

Jun 26, 2026 [9/10] PR Newswire

Anivive Lifesciences Announces FDA Approval of Laverdia®, the First Oral Treatment of Its Kind for Canine Lymphoma

Anivive Lifesciences received FDA approval for Laverdia®, the first oral treatment for canine lymphoma.

Anivive Lifesciences · FDA

Jun 25, 2026 [7/10] Coverager

Thrive Pet Healthcare partners with Pumpkin and Trupanion

Thrive Pet Healthcare has announced strategic partnerships with pet insurance and wellness providers Pumpkin and Trupanion.

Thrive Pet Healthcare · Pumpkin · Trupanion · Coverager

Jun 25, 2026 [7/10] PR Newswire

Thrive Pet Healthcare Expands Pet Insurance Access Through Pumpkin and Trupanion to Help Pet Owners Plan for Veterinary Care Costs

Thrive Pet Healthcare has expanded pet insurance access for clients by partnering with Pumpkin and Trupanion to help pet owners better manage veterinary care costs.

Thrive Pet Healthcare · Pumpkin · Trupanion · PR Newswire

Most-mentioned this week

Thrive Pet Healthcare (2)